NewAmsterdam Pharma Company N.V. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
NewAmsterdam Pharma Company N.V. (NAMS) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$12.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2026-05-07
- NewAmsterdam Pharma Company N.V. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2026-03-31 was -$12.00K.
- NewAmsterdam Pharma Company N.V. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2025-12-31 was -$11.00K.
- NewAmsterdam Pharma Company N.V. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2025-09-30 was -$1.00K.
- NewAmsterdam Pharma Company N.V. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2025 was -$12.00K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$12.00K 10-Q · filed 2026-05-07 | -$23.00K derived: sum of 2 quarters · filed 2026-05-07 | -$24.00K derived: sum of 3 quarters · filed 2026-05-07 | |
| 2025-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | -$12.00K derived: sum of 2 quarters · filed 2026-02-18 | -$12.00K 10-K · filed 2026-02-18 | |
| 2025-09-30 | -$1.00K 10-Q · filed 2025-11-05 | -$1.00K 10-Q · filed 2025-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |